1·Valproate was FDA-approved in 1995 for treatment of mania.
1995年，丙戌酸钠被FDA核准用于治疗躁狂。
2·ABSTRACT Objective: To study the influence of sodium valproate on plasma fibrinogen.
目的：研究丙戊酸钠对血浆纤维蛋白原的影响。
3·There were no significant differences between the levetiracetam and valproate groups.
左乙拉西坦组与丙戊酸钠组差异无统计学意义。
4·As a first - line agent for treating epilepsy, valproate sodium is widely used in clinic.
丙戊酸钠作为常用一线抗癫痫药，目前在临床的应用较为广泛。
5·The effects of the blood concentration weren't great on TPM to carbamazepine and valproate.
TPM对卡马西平及丙戊酸钠血药浓度影响不大。
6·Objetive the aim of this paper was to observe the clinical efficacy of valproate magnesium in mania.
目的探讨丙戊酸镁抗躁狂症的临床疗效。
7·OBJECTIVE to explore the pathogenesis of thrombocytopenic purpura caused by sodium valproate treatment.
目的探讨丙戊酸钠致血小板减少性紫癜可能发生机制。
8·Objective: to compared the pharmacokinetics of sodium valproate suppository with sodium valproate tablets.
目的：比较丙戊酸钠栓剂与片剂的药代动力学特征。
9·The higher the dosage of valproate a woman had taken, the lower the IQ of the child, the researchers found.
研究表明，一个妇女服用这种抗癫痫药物的剂量越高，他的孩子的智商越低。
10·AbstractObjectiveTo investigate the effects of valproate treatment on plasma insulin and leptin levels of epileptic children.
目的探讨丙戊酸治疗对癫疒间患儿血浆胰岛素和瘦素水平的影响。